These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 12670923
1. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. Cancer Res; 2003 Apr 01; 63(7):1684-95. PubMed ID: 12670923 [Abstract] [Full Text] [Related]
2. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK. Cancer Res; 2004 Oct 15; 64(20):7336-45. PubMed ID: 15492254 [Abstract] [Full Text] [Related]
3. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Xue A, Xue M, Jackson C, Smith RC. Int J Biochem Cell Biol; 2009 Oct 15; 41(8-9):1731-8. PubMed ID: 19433314 [Abstract] [Full Text] [Related]
4. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Aguirre Ghiso JA. Oncogene; 2002 Apr 11; 21(16):2513-24. PubMed ID: 11971186 [Abstract] [Full Text] [Related]
5. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L. Mol Biol Cell; 2001 Apr 11; 12(4):863-79. PubMed ID: 11294892 [Abstract] [Full Text] [Related]
6. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. Aguirre Ghiso JA, Kovalski K, Ossowski L. J Cell Biol; 1999 Oct 04; 147(1):89-104. PubMed ID: 10508858 [Abstract] [Full Text] [Related]
7. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Kim MS, Lee EJ, Kim HR, Moon A. Cancer Res; 2003 Sep 01; 63(17):5454-61. PubMed ID: 14500381 [Abstract] [Full Text] [Related]
8. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH. Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645 [Abstract] [Full Text] [Related]
9. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR. Cancer Res; 2006 Jun 15; 66(12):6296-303. PubMed ID: 16778206 [Abstract] [Full Text] [Related]
10. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Estrada Y, Dong J, Ossowski L. Pigment Cell Melanoma Res; 2009 Feb 15; 22(1):66-76. PubMed ID: 18983537 [Abstract] [Full Text] [Related]
11. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Junttila MR, Ala-Aho R, Jokilehto T, Peltonen J, Kallajoki M, Grenman R, Jaakkola P, Westermarck J, Kähäri VM. Oncogene; 2007 Aug 09; 26(36):5267-79. PubMed ID: 17334397 [Abstract] [Full Text] [Related]
12. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P, Zani BM. Mol Cancer; 2005 Dec 13; 4():41. PubMed ID: 16351709 [Abstract] [Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 13; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
14. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Givant-Horwitz V, Davidson B, Reich R. Cancer Res; 2004 May 15; 64(10):3572-9. PubMed ID: 15150114 [Abstract] [Full Text] [Related]
15. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM. Cancer Res; 2005 Jul 15; 65(14):6275-81. PubMed ID: 16024629 [Abstract] [Full Text] [Related]
16. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Koochekpour S, Sartor O, Hiraiwa M, Lee TJ, Rayford W, Remmel N, Sandhoff K, Minokadeh A, Patten DY. Asian J Androl; 2005 Jun 15; 7(2):147-58. PubMed ID: 15897971 [Abstract] [Full Text] [Related]
17. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M. Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214 [Abstract] [Full Text] [Related]
18. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase. Sutter AP, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H. Biochem Pharmacol; 2004 May 01; 67(9):1701-10. PubMed ID: 15081869 [Abstract] [Full Text] [Related]
19. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation. Ly DP, Corbett SA. J Surg Res; 2005 Feb 01; 123(2):200-5. PubMed ID: 15680379 [Abstract] [Full Text] [Related]
20. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ. Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]